(3Z)-1-[(3,4-Dichlorophenyl)methyl]-3-(2-phenylhydrazin-1-ylidene)-2,3-dihydro-1H-indol-2-one

Catalog No. :
ACCNWZ659
CAS No. :
303985-17-3
Molecular Formula :
C21H15Cl2N3O
Molecular Weight :
396.28

IUPAC Name:(Z)-1-(3,4-dichlorobenzyl)-3-(2-phenylhydrazineylidene)indolin-2-one

(3Z)-1-[(3,4-Dichlorophenyl)methyl]-3-(2-phenylhydrazin-1-ylidene)-2,3-dihydro-1H-indol-2-one structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g90%$552.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name(3Z)-1-[(3,4-Dichlorophenyl)methyl]-3-(2-phenylhydrazin-1-ylidene)-2,3-dihydro-1H-indol-2-one
IUPAC Name(Z)-1-(3,4-dichlorobenzyl)-3-(2-phenylhydrazineylidene)indolin-2-one
MDL No.MFCD00975829
Molecular FormulaC21H15Cl2N3O
Molecular Weight396.28
SMILESO=C1/C(=N\NC2=CC=CC=C2)C2=C(C=CC=C2)N1CC1=CC=C(Cl)C(Cl)=C1
InChI KeyPLGZBBRAGGMAJY-QQTULTPQSA-N
Synonym1-(3,4-DICHLOROBENZYL)-1H-INDOLE-2,3-DIONE 3-(N-PHENYLHYDRAZONE);1H-Indole-2,3-dione, 1-[(3,4-dichlorophenyl)methyl]-, 3-(2-phenylhydrazone)
CAS No.303985-17-3

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P280-P301+P312-P302+P352-P305+P351+P338

Synthetic Route by SureRoute

1. ACCNWZ659 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACIVNU371 route compound structure diagram
    ACIVNU37179183-19-0 In Stock
  4. Then
  5. ACCNWZ659 route product structure diagram
    ACCNWZ659303985-17-3
Inquiry

2. ACCNWZ659 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACCNWZ659 route product structure diagram
    ACCNWZ659303985-17-3
Inquiry

Comments (0)